Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLMT - US1314281049 - Common Stock

20.24 USD
+0.28 (+1.4%)
Last: 12/11/2025, 8:27:23 PM
20.24 USD
0 (0%)
After Hours: 12/11/2025, 8:27:23 PM
Fundamental Rating

2

Overall CLMT gets a fundamental rating of 2 out of 10. We evaluated CLMT against 209 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CLMT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

CLMT has a Return On Assets of -1.36%. This is in the lower half of the industry: CLMT underperforms 71.77% of its industry peers.
CLMT has a Return On Invested Capital (5.73%) which is comparable to the rest of the industry.
CLMT had an Average Return On Invested Capital over the past 3 years of 7.03%. This is significantly below the industry average of 20.87%.
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC 5.73%
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CLMT's Operating Margin of 3.51% is on the low side compared to the rest of the industry. CLMT is outperformed by 67.94% of its industry peers.
CLMT's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 8.21%, CLMT is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CLMT has declined.
Industry RankSector Rank
OM 3.51%
PM (TTM) N/A
GM 8.21%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1

2. Health

2.1 Basic Checks

CLMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CLMT has more shares outstanding
The number of shares outstanding for CLMT has been increased compared to 5 years ago.
The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CLMT has an Altman-Z score of 1.22. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
CLMT's Altman-Z score of 1.22 is in line compared to the rest of the industry. CLMT outperforms 47.85% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACC0.57
WACC10.12%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLMT has a Current Ratio of 1.13. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
CLMT has a Current ratio of 1.13. This is comparable to the rest of the industry: CLMT outperforms 49.28% of its industry peers.
CLMT has a Quick Ratio of 1.13. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT's Quick ratio of 0.62 is on the low side compared to the rest of the industry. CLMT is outperformed by 70.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.33% over the past year.
CLMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.49%.
Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%

3.2 Future

CLMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.17% yearly.
CLMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.84% yearly.
EPS Next Y74.5%
EPS Next 2Y22.75%
EPS Next 3Y27.83%
EPS Next 5Y29.17%
Revenue Next Year0.19%
Revenue Next 2Y-0.47%
Revenue Next 3Y6.41%
Revenue Next 5Y5.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 65.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.07
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CLMT's earnings are expected to grow with 27.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.75%
EPS Next 3Y27.83%

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CALUMET INC

NASDAQ:CLMT (12/11/2025, 8:27:23 PM)

After market: 20.24 0 (0%)

20.24

+0.28 (+1.4%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-26 2026-02-26
Inst Owners52.8%
Inst Owner Change2.15%
Ins Owners2.95%
Ins Owner Change-0.86%
Market Cap1.76B
Revenue(TTM)4.05B
Net Income(TTM)-37.20M
Analysts78.33
Price Target22.25 (9.93%)
Short Float %12.36%
Short Ratio11.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)369.74%
Min EPS beat(2)-407.62%
Max EPS beat(2)1147.11%
EPS beat(4)2
Avg EPS beat(4)105.83%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)44.84%
EPS beat(12)6
Avg EPS beat(12)-404.2%
EPS beat(16)6
Avg EPS beat(16)-335.84%
Revenue beat(2)2
Avg Revenue beat(2)4.63%
Min Revenue beat(2)0.47%
Max Revenue beat(2)8.78%
Revenue beat(4)4
Avg Revenue beat(4)4.89%
Min Revenue beat(4)0.47%
Max Revenue beat(4)9.31%
Revenue beat(8)8
Avg Revenue beat(8)7.08%
Revenue beat(12)11
Avg Revenue beat(12)7.22%
Revenue beat(16)15
Avg Revenue beat(16)10.04%
PT rev (1m)7.38%
PT rev (3m)8.72%
EPS NQ rev (1m)-65.48%
EPS NQ rev (3m)-52.41%
EPS NY rev (1m)84.74%
EPS NY rev (3m)83.79%
Revenue NQ rev (1m)-3.36%
Revenue NQ rev (3m)-4.96%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14.07
EPS(TTM)-1.15
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS46.66
BVpS-8.01
TBVpS-8.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE 7.26%
ROIC 5.73%
ROICexc 6.03%
ROICexgc 6.03%
OM 3.51%
PM (TTM) N/A
GM 8.21%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
ROICexc(3y)7.12%
ROICexc(5y)N/A
ROICexgc(3y)8.23%
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.77%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.65%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.38
Cap/Depr 43.36%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.22
F-Score4
WACC10.12%
ROIC/WACC0.57
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
EPS Next Y74.5%
EPS Next 2Y22.75%
EPS Next 3Y27.83%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%
Revenue Next Year0.19%
Revenue Next 2Y-0.47%
Revenue Next 3Y6.41%
Revenue Next 5Y5.84%
EBIT growth 1Y1018.9%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3218.2%
EBIT Next 3Y299.56%
EBIT Next 5Y148.39%
FCF growth 1Y83.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALUMET INC / CLMT FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status of CALUMET INC (CLMT) stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


Can you provide the profitability details for CALUMET INC?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CLMT stock?

The Earnings per Share (EPS) of CALUMET INC (CLMT) is expected to grow by 74.5% in the next year.